iFIT Seminar Series with Dr. Stefani Spranger
Not all anti-tumor T cell responses are equal: tissue-site matters
On behalf of the iFIT spokespersons Lars Zender, Hans-Georg Rammensee and Bernd Pichler, it is our pleasure to inform you about and invite you to the next episode of our iFIT Seminar Series 2023 that will take place
on Monday, June 5th at 12:00 pm s.t. (CEST)
at Crona HS 210 (Crona Kliniken, Hoppe-Seyler-Straße 3, 72076 Tübingen).
Our guest speaker Dr. Stefani Spranger from Koch Institute for Integrative Cancer Research MIT will give a talk on
“Not all anti-tumor T cell responses are equal: tissue-site matters”.
“Cancer immunotherapies, first and foremost checkpoint blockade therapy (anti-CTLA4 and anti-PD-1/PD-L1), have revolutionized cancer treatment. Despite these advances only a fraction of cancer patients responds to immunotherapeutic interventions. Even for cancer types that typically show high response rates, only a fraction of patients respond. We aim to understand which tumor cell-intrinsic, tissue-macroenvironmental and environmental factors mediate resistance mechanisms against immunotherapy by affecting T cell infiltration into tumors.”
As a special feature of this program, the iFIT will sponsor free lunch packages! (First come, first serve)
All members of the University Hospital and University of Tübingen are invited to participate!
We look forward to this Seminar Series session and to see you there!
